14 Sep 2020 16:30
14 September 2020
4D pharma plc
(the "Company" or "4D")
Block Listing Six Monthly Return
Name of applicant: | 4D Pharma plc | |||
Name of scheme: | Block Admission for February 2020 warrants | |||
Period of return: | From: | 10 March 2020 | To: | 9 September 2020 |
Number of securities originally admitted at date of admission: | 22,000,000 Ordinary Shares of 0.25p each on 10 March 2020 | |||
Balance of unallotted securities under scheme(s) from previous return: | 22,000,000 Ordinary shares | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 Ordinary shares | |||
Less: Number of securities issued/allotted under scheme(s) during period: | 0 Ordinary shares | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 22,000,000 Ordinary shares | |||
Name of contact: | Duncan Peyton |
Telephone number of contact: | Company Secretary (0113 895 0130) |
Contact Information:
4D
Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130
Investor Relations ir@4dpharmaplc.com
N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000
Aubrey Powell / Justin McKeegan / Iqra Amin (Corporate Finance)
Tom Salvesen (Corporate Broking)
Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332 2500
Dominic Wilson / Phil Walker
Image Box Communications
Neil Hunter / Michelle Boxall +44 (0)20 8943 4685